Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group

PURPOSE: Given concerns that dexrazoxane may reduce treatment efficacy, induce second cancers, and thus compromise overall survival among children, we examined long-term overall and cause-specific mortality and disease relapse rates from three randomized clinical trials. PATIENTS AND METHODS: Childr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Chow, Eric J., Asselin, Barbara L., Schwartz, Cindy L., Doody, David R., Leisenring, Wendy M., Aggarwal, Sanjeev, Baker, K. Scott, Bhatia, Smita, Constine, Louis S., Freyer, David R., Lipshultz, Steven E., Armenian, Saro H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534526/
https://ncbi.nlm.nih.gov/pubmed/26014292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.4473
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares